KR100422568B1 - Production of inorganic antimicrobial agent having high antibacterial potency suitable for manufacture of antimicrobial resin as well as improved color and low toxicity by treating waste supported silver catalyst - Google Patents

Production of inorganic antimicrobial agent having high antibacterial potency suitable for manufacture of antimicrobial resin as well as improved color and low toxicity by treating waste supported silver catalyst Download PDF

Info

Publication number
KR100422568B1
KR100422568B1 KR1019950069085A KR19950069085A KR100422568B1 KR 100422568 B1 KR100422568 B1 KR 100422568B1 KR 1019950069085 A KR1019950069085 A KR 1019950069085A KR 19950069085 A KR19950069085 A KR 19950069085A KR 100422568 B1 KR100422568 B1 KR 100422568B1
Authority
KR
South Korea
Prior art keywords
silver
catalyst
antimicrobial agent
antimicrobial
inorganic
Prior art date
Application number
KR1019950069085A
Other languages
Korean (ko)
Other versions
KR970032398A (en
Inventor
윤대영
이복희
이창열
권오준
Original Assignee
삼성아토피나주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 삼성아토피나주식회사 filed Critical 삼성아토피나주식회사
Priority to KR1019950069085A priority Critical patent/KR100422568B1/en
Publication of KR970032398A publication Critical patent/KR970032398A/en
Application granted granted Critical
Publication of KR100422568B1 publication Critical patent/KR100422568B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02Sterilising, e.g. of complete packages
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/50Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D5/00Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
    • C09D5/14Paints containing biocides, e.g. fungicides, insecticides or pesticides
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Hydrology & Water Resources (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Water Supply & Treatment (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Dentistry (AREA)
  • Mechanical Engineering (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Materials Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PURPOSE: Provided is a method of making an inorganic antimicrobial agent by treating a waste supported silver catalyst, wherein the silver is supported on porous alumina, in three stages including a chlorination reaction, calcination, grinding and classification. The product has high antibacterial potency suitable for the manufacture of antimicrobial resin as well as improved color and low toxicity. CONSTITUTION: A waste supported silver catalyst, wherein the silver is supported on porous alumina for production of ethylene oxide is treated in three stages including a negative ion introduction reaction, calcination, grinding and classification to produce an inorganic antimicrobial agent. In the negative ion introduction reaction, the waste supported silver catalyst and negative ion are introduced into a reactor and then reacted at 0 to 50deg.C at 1 to 10atm. The calcination is performed at 100 to 300deg.C for 1 to 3hr in air, the classification is achieved by grinding the catalyst and separating particles having an average particle size of 0.05 to 20μm. The negative ion is one or more selected from chlorine, nitrogen, phosphoric acid, hydrogen oxide, ammonium, amine or organic acid groups.

Description

은담지촉매 폐기물을 이용한 무기계 항균제의 제조방법Manufacturing method of inorganic antibacterial agent using silver catalyst catalyst waste

본 발명은 산화에틸렌 제조용 은담지촉매 폐기물을 재처리하여 세균 및 곰팡이에 효과가 좋고 안정성이 확보된(독성이 없는) 무기계 항균성 화합물을 제조하는 방법에 관한 것으로서, 더욱 상세하게는 은이 다공성 무기질 담체에 골고루 담지되어 있는 은담지촉매를 재처리하여 항균성 수지의 제조에 사용가능한 항균력이 높고, 독성이 적은 무기계 항균성 화합물을 제조하는 방법에 관한 것이다.The present invention relates to a method for producing an inorganic antimicrobial compound having good stability and non-toxic effect on bacteria and fungi by reprocessing silver supported catalyst waste for producing ethylene oxide, and more particularly, silver is added to a porous inorganic carrier. The present invention relates to a method for producing an inorganic antimicrobial compound having high antibacterial activity and low toxicity, which can be reprocessed evenly supported silver supported catalyst.

에틸렌과 분자상의 산소의 기상접촉부분 산화반응에 의하여 산화에틸렌을 제조하기 위한 촉매는 은이 다공성 무기질 담체에 골고루 담지되어 있는 형태인데, 이러한 은담지촉매를 산화에틸렌 반응에 오랜기간(약2~5년)동안 사용하면 수율 및선택도가 낮아져서 새로운 촉매로 고체하게 된다. 이러한 이유로 발생한 폐촉매는 귀금속인 은이 많이 포함되어 있으므로(3∼16%) 은을 회수하거나, 회수비용이 많이드는 경우에는 전량폐기하고 있는 실정이다. 그러나, 기존의 이러한 처리방법은 환경문제를 유발시킬 수 있으므로 좋은 방법이 되지 못한다.The catalyst for producing ethylene oxide by gas phase contact partial oxidation of ethylene and molecular oxygen is in a form in which silver is evenly supported on a porous inorganic carrier, and the silver supported catalyst has been used for a long time (about 2 to 5 years). When used for), the yield and selectivity are lowered, making it solid with a new catalyst. The waste catalyst generated for this reason contains silver, which is a noble metal (3 to 16%), and the silver is recovered or disposed of in case of high recovery cost. However, this conventional method is not good because it can cause environmental problems.

세균 및 곰팡이에 의하여 발생되는 문제점을 개선하기 위하여 사용되는 항균성 수지용 항균체는 일반적으로 유기계 항균제와 무기계 항균제로 나눌 수 있다. 무기계 항균제는 은, 구리, 아연 등과 같은 항균금속을 제올라이트, 실리카, 알루미나, 인산지르코늄 등과 같은 담체에 골고루 분산시킨 것으로 가격이 비싸다는 단점에도 불구하고, 제4암모늄염 화합물, 양이온성 질소화합물 등을 주성분으로 하는 유기계 항균제보다 지속적인 효과를 보장할 수 있으며, 내열성이 높고, 안정성이 높다는 이유로 항균성 수지조성물의 제조에 널리 사용되고 있다.Antimicrobials for antimicrobial resins used to improve the problems caused by bacteria and fungi can be generally divided into organic and inorganic antimicrobials. Inorganic antimicrobial agent is an even dispersion of antibacterial metals such as silver, copper, zinc and the like on a carrier such as zeolite, silica, alumina, zirconium phosphate, etc. It is possible to ensure a lasting effect than the organic type antimicrobial agent, and has been widely used in the production of antimicrobial resin compositions because of high heat resistance and high stability.

상업적으로 생산되는 무기계 항균제는 은, 구리, 아연, 수은, 주석, 납, 비스무스, 카드늄, 크롬, 파라듐 등에서 선택된 적어도 한가지 이상의 항균성 금속을 천연 제올라이트, 합성 제올라이트, 실리카, 알루미나, 인산지르코늄 등의 담체에 이온교환법 또는 습식법을 이용하여 담지시킨 것이다. 이러한 무기계 항균제중 은을 주성분으로 하는 무기계 항균제는 독성이 없으므로 인체와 접촉 가능한 성형물에 사용되는 항균제로 가장 많이 사용되고 있으나 가격이 매우 비싼 실정이다.Commercially produced inorganic antimicrobial agents include at least one antimicrobial metal selected from silver, copper, zinc, mercury, tin, lead, bismuth, cadmium, chromium, palladium, and the like, such as natural zeolite, synthetic zeolite, silica, alumina, zirconium phosphate, and the like. It is supported by the ion exchange method or the wet method. Among these inorganic antimicrobials, the inorganic antimicrobial agent containing silver as the main component is not toxic, so it is most used as an antimicrobial agent used in moldings that can come into contact with the human body, but the price is very high.

본 발명에서는 산화에틸렌 제조용 폐촉매가 무기계 항균제와 구성이 동일함을 발견하고, 이를 원료로 항균제로서 가져야될 기능인 항균력이 높고 독성이 적은 항균성 수지용 무기계 항균제로 재처리하는 방법을 제공하는데 목적이 있다.In the present invention, the purpose of the present invention is to find that the waste catalyst for producing ethylene oxide has the same composition as an inorganic antimicrobial agent, and to provide a method of reprocessing the inorganic antimicrobial agent for antimicrobial resin having a high antimicrobial activity and a low toxicity which is a function to be used as an antimicrobial agent as a raw material. .

즉, 본 발명의 목적은 항균성 수지용 무기계 항균제를 제조하는 방법에 있어서, 산화 애틸렌 제조용 은담지촉매 폐기물을 활용하여 항균력이 높고 독성이 적은 무기계 항균제를 제조하는 것을 특징으로 하는 무기계 항균성 화합물의 제조방법을 제공하는 것이다.That is, an object of the present invention is to prepare an inorganic antimicrobial compound, characterized in that in the method for producing an inorganic antimicrobial agent for antimicrobial resin, by using a silver supported catalyst waste for the production of ethylene oxide to prepare an inorganic antimicrobial agent having high antibacterial activity and low toxicity. To provide a way.

공업적으로 에틸렌을 접촉합성반응에 의하여 산화에틸렌으로 만드는 산화공정에 사용되는 촉매로는 은을 다공성인 무기담체에 담지한 촉매만이 유일한 것으로 알려져 있다. 그러나 최근에 높은 수율의 산화에틸렌을 얻기 위하여 제조된 촉매는 주촉매인 은(0.5~20%)과 반응촉진제겸 활성부여제로서 알칼리금속 및 알칼리토금속류(1% 미만)를 첨가하여 다공성의 담체에 담지시켜 적당한 크기와 형태를 갖도록 성형시켜 놓은 것이 일반적이다. 이러한 산화에틸렌 제조용 촉매는 사용중에 여러가지 오염요소에 의하여 촉매의 활성이 감소되어 더이상 사용이 어렵게 되고, 이런 경우에 발생되는 폐촉매는 사용이력에 따라 나타내는 성질이 달라지게 된다.It is known that the only catalyst used in the oxidation process for converting ethylene into ethylene oxide by catalytic synthesis is silver which is supported on a porous inorganic carrier. Recently, however, a catalyst prepared to obtain high yield of ethylene oxide is a porous carrier by adding silver (0.5-20%) as the main catalyst and alkali metals and alkaline earth metals (less than 1%) as reaction promoters and activators. It is generally molded to have a suitable size and shape by supporting it. The catalyst for producing ethylene oxide is difficult to use any more because the activity of the catalyst is reduced by various contaminants during use, and the waste catalyst generated in such a case varies depending on the history of use.

0.5 내지 20중량%의 은이 다공성 담체에 미세하게 분포되어 있는 산화에틸렌 제조용 촉매는 무기계 항균제와 구성요소가 유사하여 직접 항균제로 사용가능한 것처럼 보이나, 항균활성이 낮으며, 색상이 흑갈색이며, 인체에 해로운 미량의 휘발성 물질이 포함될 수 있다는 점 때문에 산화에틸렌 제조용 촉매 자체로는 항균제로 사용하기 어렵다.The catalyst for producing ethylene oxide having 0.5 to 20% by weight of silver finely distributed in the porous carrier may be used as a direct antimicrobial agent due to similar components to the inorganic antimicrobial agent, but the antimicrobial activity is low, the color is blackish brown, and it is harmful to the human body. The catalyst for preparing ethylene oxide itself is difficult to use as an antimicrobial agent because it may contain a trace amount of volatiles.

따라서 본 발명에서는 이러한 약점을 개량하기 위하여 항균력 및 색도를 증가시키기 위한 업소화 반응단계, 폐촉매에 남아있을 수 있는 휘발성 물질을 제거하기 위한 소성단계, 항균제에 적합한 입자분포를 갖도록 만드는 분쇄단계의 3단계의처리에 의하여, 은담지 폐촉매를 이용하여 항균력 및 백색도가 우수한 무기계 항균제를 제조하는 방법을 제공한다. 각 단계의 순서는 경우에 따라서 서로 바뀌어도 무방하다.Therefore, in the present invention, in order to improve this weakness, 3 of the ignition reaction step to increase the antimicrobial power and color, the calcination step to remove volatiles that may remain in the waste catalyst, the grinding step to have a particle distribution suitable for the antimicrobial agent By the step treatment, a method for producing an inorganic antimicrobial agent having excellent antibacterial activity and whiteness using a silver supported waste catalyst is provided. The order of the steps may be changed in some cases.

본 발명의 방법에서는 항균력을 높이기 위하여 은계 항균활성 기작(Mechanism)을 이용하였다. 지금까지 제안된 은계 항균제 항균활성 기작에 의하면, 용출설을 받아들일 때는 은의 용출량이 증가될수록, 활성산소설을 받아들일 때는 은의 이온성을 증가시킬수록 항균성을 높혀줄 수 있다. 일반적으로 은의 이온성을 증가시키는 것에 의하여 은의 용출량도 증가시킬 수 있기 때문에 항균성을 증가시키기 위해서는 은의 이온성을 증가시켜야 한다. 은의 이온성을 높히는 방법으로는 금속은을 염소기, 질산기, 인산기, 수산기, 암모늄기, 아민기 또는 유기산기 등으로 치환하는 방법을 들 수 있다. 그러나 염소기를 도입하는 방법은 항균력 및 백색도를 동시에 개선할 수 있으므로 염소기를 도입하는 것이 가장 바람직하다.In the method of the present invention, a silver-based antimicrobial activity mechanism (Mechanism) was used to increase the antimicrobial activity. According to the antimicrobial activity mechanism of the silver-based antimicrobial agent proposed so far, the higher the elution amount of silver when accepting elution, and the higher the ionicity of silver when accepting active oxygen, the higher the antimicrobial activity. In general, since the elution amount of silver can be increased by increasing the ionicity of silver, the ionicity of silver must be increased to increase the antimicrobial activity. As a method of increasing the ionicity of silver, the method of substituting metal silver with a chlorine group, a nitric acid group, a phosphoric acid group, a hydroxyl group, an ammonium group, an amine group, or an organic acid group is mentioned. However, the method of introducing a chlorine group is most preferable to introduce a chlorine group because it can improve the antibacterial activity and whiteness at the same time.

염소화 방법은 일반적으로 금속상의 은을 착화합물로 만들고 염산을 가하는 습식법이 사용되나, 이 방법은 많은 양의 폐수가 발생하고 반응의 조절이 어려움으로 본 발명에서는 폐촉매에 염소를 직접 주입하는 방법을 이용한다. 염소화 반응량의 조절은 반응기 내부의 온도와 압력을 조절함에 의하여 얻을 수 있으며, 사용온도는 O℃ 내지 50℃이었으며, 반응압력은 1 기압 내지 10 기압을 사용하는 것이 좋지만, 바람직하게는 반응온도를 20℃ 내지 40℃하고 반응압력을 1기압 내지 4 기압으로 조절하는 것에 의하여 담체내에 포함된 은이 염화은으로 바뀐 비율을 1% 내지 100%로 조절할 수 있으나, 항균력, 색상 및 경시변화의 3대 항균물성을 만족하는바람직한 범위는 10% 내지 90% 이다.In general, the chlorination method uses a wet method of complexing silver metal with hydrochloric acid, but this method uses a method of directly injecting chlorine into the waste catalyst because a large amount of wastewater is generated and the control of the reaction is difficult. . Controlling the amount of chlorination reaction can be obtained by controlling the temperature and pressure in the reactor, the operating temperature was O ℃ to 50 ℃, the reaction pressure is preferably used 1 to 10 atm, but preferably the reaction temperature By adjusting the reaction pressure at 20 ℃ to 40 ℃ and the pressure of 1 to 4 atm can be adjusted to 1% to 100% of the rate of silver contained in the carrier to silver chloride, but three antimicrobial properties of antibacterial activity, color and change over time The preferred range to satisfy is 10% to 90%.

염소화 반응을 거친 폐촉매에서 미반응 염소와 촉매상에 남아있을지도 모를 소량의 수분 및 유기물을 제거시켜주기 위하여 100℃ 내지 300℃로 공기중에서 1시간 내지 3시간 소성시켜주는 것이 바람직하다. 염소화반응 및 소성과정을 통하여 강열잔분 0.1% 이내, 5% 슬러리로 측정된 산도(pH)가 6 내지 8 값을 갖는, 휘발성 물질을 거의 포함하고 있지 않고 중성인 무기화합물을 얻을 수 있다.In order to remove a small amount of water and organic matter which may remain on the unreacted chlorine and the catalyst in the chlorination reaction, it is preferable to bake for 1 hour to 3 hours in air at 100 ℃ to 300 ℃. Through the chlorination and calcining process, a neutral inorganic compound containing almost no volatile substance having a pH value of 6 to 8, measured in 5% slurry within 0.1% of ignition residue, can be obtained.

무기항균제로 제조하기 위한 마지막 단계는 상기 과정에서 얻은 중성의 무기화합물을 사용되는 매질에 골고루 분산시켜 고항균력을 유지시키기 위한 분쇄 및 분류과정이다. 고항균력 유지 및 매질과의 분산을 위해서는 가능한 평균입자크기가 0.05 미크론 내지 20 미크론으로 하는 것이 좋지만, 바람직하게는 항균섬유용으로는 0.1 미크론 내지 1 미크론, 일반응으로는 1 미크론 내지 10 미크론의 평균입도를 갖도록 하는 것이 좋다.The final step for preparing the inorganic antimicrobial agent is the grinding and classification process for maintaining the high antibacterial power by uniformly dispersing the neutral inorganic compound obtained in the above process in the medium used. In order to maintain high antimicrobial activity and to disperse with the medium, it is recommended that the average particle size be 0.05 to 20 microns, but preferably 0.1 micron to 1 micron for antibacterial fibers and 1 micron to 10 microns for one reaction. It is good to have a particle size.

이와 같은 방법에 의하여 제조된 본 발명의 은담지 폐촉매로부터 제조된 무기항균제의 안정성(독성)은 급성경구독성, AMES 시혐 및 중금속용출시험 항목에 의하여 평가되었다. 급성경구독성 시험은 보건사회부 제87-80호(1987. 10. 29.)의 "의약품 안정성 시험 관리기준"에 준하여 시험방법은 국립보건안전연구원 제94-3호(1994. 4. 14.)의 "의약품 등의 독성시험기준"에 따라 SD 계통의 렛트 암수 각각 5마리에 일정용량으로 1회 경구투여하여 사망율, 일반증상, 체중변화 및 부검소견을 관찰한 결과로 평가된다. AMES 시험은 미국의 캘리포니아 대학의 아메스(Ames) 교수에 의하여 제안된 방법으로 미국환경보호청 및 일본의 노동성에서 돌연변이원성, 발암성 및 안정성의 판단기준으로 사용된다. 시험은 살모넬라 티피머리움 TA100(Salmonella typhimurium TA100) 및 살모넬라 티피머리움 TA98(Salmonella typhimurium TA98) 세균에 일정농도를 투여하여 돌연변이의 발생을 관찰하는 것에 의하여 평가된다.The stability (toxicity) of the inorganic antimicrobial agent prepared from the silver supported waste catalyst of the present invention prepared by such a method was evaluated by acute oral toxicity, AMES test and heavy metal dissolution test items. The acute oral toxicity test was conducted in accordance with the "Medical Stability Test Management Criteria" of the Ministry of Health and Social Affairs No. 87-80 (October 29, 1987). According to the "Toxicity Test Standards for Drugs," it is evaluated as the result of mortality, general symptoms, weight change and autopsy findings by oral administration to each of the five male and female rats of SD system at a fixed dose. The AMES test, proposed by Professor Ames of the University of California, USA, is used as a criterion for mutagenicity, carcinogenicity, and stability in the US Environmental Protection Agency and the Labor Department in Japan. The test is assessed by monitoring the development of mutations by administering a constant concentration to Salmonella typhimurium TA100 and Salmonella typhimurium TA98 bacteria.

항균제의 항균특성은 각종 일반세균, 효모류 및 진균류에 관하여 최소성장억제농도(MIC)로서 추정될 수 있다. 최소성장억제농도(MIC)는 뮐러-힌튼브로스(Muller-Hinton Broth)에 항균제를 농도별로 처방 후 일정량의 균액을 접종하여 35℃에서 24시간 쉐이킹 인큐베이터(Shaking incubator)에서 배양후 육안으로 균일 성장유무를 확인하여 균의 성장이 억제된 최저농도로 결정한다.The antimicrobial properties of the antimicrobial agent can be estimated as the minimum growth inhibitory concentration (MIC) for various general bacteria, yeasts and fungi. The minimum growth inhibitory concentration (MIC) is prescribed by Muller-Hinton Broth, and then inoculated with a certain amount of microbial solution, followed by incubation in a shaking incubator at 35 ° C for 24 hours, followed by visual growth. Determine the minimum concentration to inhibit the growth of bacteria.

항균제의 특성중에 다음으로 중요한 물성은 색상이다. 항균제의 색상이 무색이면 여러가지 색상의 제품을 다양하게 만들 수 있기 때문에 가장 바람직하다. 본 제조방법에 의하여 합성된 무기항균제는 이온성의 은염인 염화은의 함량을 증가시킬수록 백색도도 증가시킬 수 있으나, 태양광에 의하여 변색이 발생하는 단점이 있다. 그러나 태양광에 의한 변색이 항균력의 성능에는 변화를 주지 않으므로 용도에 따라(실내용, 실외용) 염화은의 비율을 조절함에 의하여 항균조성물에 사용될 수 있다.Among the properties of antimicrobials, the next most important property is color. If the color of the antimicrobial is colorless, it is most desirable because it can make a variety of products of different colors. The inorganic antimicrobial agent synthesized by the present method may increase the whiteness as the content of silver chloride, an ionic silver salt, increases, but there is a disadvantage in that discoloration occurs due to sunlight. However, since the discoloration by sunlight does not change the performance of the antimicrobial activity, it can be used in the antimicrobial composition by adjusting the ratio of silver chloride according to the use (indoor and outdoor).

본 발명에 의하여 제조된 항균제는 항균수직조성물, 페인트분야, 건축분야, 제지분야 등에서 일반세균, 효모 및 진균류에 의해서 야기되는 문제의 해결을 위하여 제공된다.The antimicrobial agent prepared according to the present invention is provided for solving problems caused by general bacteria, yeasts and fungi in the antimicrobial woven fabric, paint field, construction field, papermaking field and the like.

항균수지 분야는 수지에 항균 및 항진균의 특성을 부여하기 위하여 전술한항균제를 수지와 함께 반죽함으로써 함입시키거나 또는 이러한 수지의 표면에 피복함으로써 제조된다. 수지는 폴리에틸렌, 폴리프로필렌, 염화폴리비닐, 폴리스티렌, ABS수지, 폴리에스테르수지, 나일론, 폴리아마이드, 폴리비닐알코올, 폴리비닐아세테이트, 폴리카보네이트, 폴리우레탄, 에폭시수지, 레이온수지, 천연 또는 합성고무 등을 포함한다.The antimicrobial resin field is prepared by impregnating the above-mentioned antimicrobial agent with a resin or coating the surface of such a resin to impart antimicrobial and antifungal properties to the resin. The resin is polyethylene, polypropylene, polyvinyl chloride, polystyrene, ABS resin, polyester resin, nylon, polyamide, polyvinyl alcohol, polyvinylacetate, polycarbonate, polyurethane, epoxy resin, rayon resin, natural or synthetic rubber, etc. It includes.

페인트 분야에서는 본 발명의 항균제를 친유성 페인트 라커, 니스 및 알키드 수지형, 비닐수지형, 아크릴수지형, 에폭시수지형, 우레탄수지형, 페놀수지형의 용액상 또는 분말상 페인트에 직접 혼입하거나 피복된 필름의 표면에 코팅함으로써 항균 및 항진균의 특성을 부여할 수 있다.In the paint field, the antimicrobial agent of the present invention is directly incorporated into or coated with a lipophilic paint lacquer, varnish and alkyd resin type, vinyl resin type, acrylic resin type, epoxy resin type, urethane resin type, phenol resin type solution or powder type paint. Coating on the surface of the film can impart antimicrobial and antifungal properties.

건설분야에서는 본 발명의 항균제를 벽, 천정등의 마감제, 건축용 또는 놀이터용 모래, 타일 등과 같은 각종 건축용 부품의 재료에 혼입하거나 표면에 코팅함에 의하여 항균 및 항진균 특성을 부여할 수 있다.In the construction field, antimicrobial and antifungal properties may be imparted by incorporating the antimicrobial agent of the present invention into a material of various building parts such as walls, ceiling finishes, building or playground sand, tiles, and the like.

본 발명의 무기항균제는 물티슈페이퍼, 종이포장지, 골판지 등에 선도유지용으로, 물세정제, 각종 냉각수의 항조류 약품으로 사용되는 등 전술된 분야 이외에도 미생물이 발육이 억제되어야 되는 모든 분야에 사용된다.Inorganic antimicrobial agents of the present invention are used in all areas in which microorganisms should be suppressed in addition to the above-described fields, such as water cleaners, antibacterial drugs for various cooling waters, and the like for use in fresh tissue paper, paper packaging paper, corrugated paper, and the like.

이러한 항균조성물에서 사용되는 항균제와 함량은 항균제 자체의 최소억제율(MIC)의 10~100배 농도 범위에서 결정되며, 사용되는 항균제의 함량은 0.01중량% 내지 10중량%이며, 바람직하게는 0.5중량% 내지 5중량%에 이르는 것이 적합하다.The antimicrobial agent and the content used in the antimicrobial composition are determined in the concentration range of 10 to 100 times the minimum inhibitory rate (MIC) of the antimicrobial agent itself, and the content of the antimicrobial agent used is 0.01% by weight to 10% by weight, preferably 0.5% by weight. Suitably up to 5% by weight.

이하 실시예를 통하여 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail through examples.

실시예 1 <항균제의 제조>Example 1 <Preparation of Antimicrobial Agents>

사용된 원료로 신촉매(Scientific design co., Inc.(미국), 상품명 : Syndox-845) 및 이를 3.2년간 사용한 폐촉매를 항균제의 제조원료로 사용하였다. 신촉매는 금속상의 은(Ag) 8.5%과 기타 알칼리금속 1% 이내를 다공성 감마 알루미나에 담지하여 Φ10X15mm 크기의 원통형으로 성형되어 있다. 폐촉매는 위의 신촉매를 반응기에 담지하여 상업공장에서 3.2년 사용 후 꺼낸 촉매로 산화에틸렌 제조용으로는 더이상 사용하기 어려운 촉매이다. 신촉매 및 폐촉매의 보관은 비닐백에 담아서 냉암소에서 신촉매는 약 4년, 폐촉매는 약 8개월동안 보관한 것이다.As a raw material used, a new catalyst (Scientific design co., Inc. (US), trade name: Syndox-845) and a waste catalyst used for 3.2 years were used as raw materials for the production of antimicrobial agents. The new catalyst is molded into a Φ10 × 15 mm cylinder by supporting porous gamma alumina with 8.5% silver (Ag) and less than 1% of other alkali metals. The waste catalyst is a catalyst which is carried out after 3.2 years of use in a commercial plant by supporting the new catalyst in a reactor, and is a catalyst that is no longer used for ethylene oxide production. The new and spent catalysts were stored in plastic bags for 4 years for new catalysts and 8 months for spent catalysts in cold and dark places.

항균제로의 재가공 방법은 분쇄를 먼저 하고 염소화반응 및 소성을 나중에 하는 방법으로 실시하였다. 먼저 원통형의 촉매를 유리분쇄용 햄머밀을 사용하여 평균입자크기가 2~3㎛되게 분쇄하였다. 분쇄된 촉매 300g을 은도계, 압력계, 교반기가 부착된 반응기에서 교반속도는 700~1000rpm으로 고정하고, 일정량(10g)의 염소를 주입하고나서 반응압력 및 온도를 조절하고 30분동안 교반하였다. 반응이 끝난 후(30분 후) 반응기 내부를 질소로 충분히 펴지시켜준 후 꺼내어서 공기중에서 150℃로 3시간 동안 소성하였다. 이렇게 만들어진 시료중의 은은 금속상의 은(Ag)에서 이온상의 은염(AgCl)으로 바뀐다. 이를 XRD(X선 회절분석)를 사용하여 확인하였으며, 조성분석은 은이 염화은으로 바뀌면 1:1 질산에 녹지 않으므로, 먼저 금속상 은을 1:1 질산으로 녹여내어 은(Ag)의 농도로 분석하여 나머지는 염화은에 포함된 이온상 은염으로 규정하였다.Reprocessing with an antimicrobial agent was carried out by grinding first and chlorination and firing later. First, the cylindrical catalyst was ground to an average particle size of 2 to 3 µm using a glass mill hammer mill. 300 g of the pulverized catalyst was fixed at 700-1000 rpm in a reactor equipped with a silver gauge, a pressure gauge, and a stirrer, and a constant amount (10 g) of chlorine was injected, and then the reaction pressure and temperature were adjusted and stirred for 30 minutes. After the reaction was completed (after 30 minutes), the inside of the reactor was sufficiently expanded with nitrogen, and then taken out and calcined at 150 ° C. in air for 3 hours. The silver in this sample is changed from silver (Ag) on the metal to silver salt (AgCl) on the ionic phase. This was confirmed using XRD (X-ray diffraction analysis), and composition analysis is not dissolved in 1: 1 nitric acid when silver is changed to silver chloride, so first dissolve the metallic silver with 1: 1 nitric acid and analyze it by the concentration of silver (Ag). The rest were defined as ionic silver salts contained in silver chloride.

먼저 표 1에 의하면 반응온도를 낮출수록 압력을 높힐수록 금속상의 은을 이온상의 은염인 염화은으로 많이 바꿀 수 있었다. 위의 결과를 확인하기 위한 시료의 XRD 그래프를, 원료로 사용한 신촉매와 비교하여 제1도에 나타내었다. 신촉매는 금속상 은이 알루미나 담체에 포함되어 있으므로 금속상 은(Ag) 및 담체의 회절 피크만 나타났지만, 본 발명의 제조방법에 의하여 만들어진 시료는 금속상 은(Ag) 뿐만 아니라 염화은(AgCl)이 같이 공존하고 있다.First, according to Table 1, as the reaction temperature was lowered and the pressure was increased, the metallic silver was converted into silver chloride, an ionic silver salt. The XRD graph of the sample for confirming the above result is shown in FIG. 1 compared with the new catalyst used as a raw material. As the new catalyst contained metallic silver in the alumina carrier, only the diffraction peaks of the metallic silver (Ag) and the carrier appeared, but the samples prepared by the manufacturing method of the present invention were not only silver (Ag) but also silver chloride (AgCl). Coexist together.

표 1Table 1

실시예 2 <제조된 항균제의 물성 및 항균력>Example 2 <Physical Properties and Antibacterial Activity of Prepared Antibacterials>

상기와 같이 합성된 시료의 대표물성으로 5% 슬러리의 산도(pH)와 헌터 색도계(Hunter Colorimeter)를 사용하여 백색도(WI)를 측정하였으며, 항균력은 대장균(E. Coli ATCC 25922)을 대표균주로 하여 최소성장억제농도(MIC)를 측정하여 표 1 및 제2도에 표시하였다. 이 때 비교데이타로 신촉매를 입자크기만 실시예 1과 동일하게 분쇄하여 측정하였다.As a representative physical property of the sample synthesized as described above, the whiteness (WI) was measured using a pH (pH) and a Hunter Colorimeter (5%) of the slurry, and the antimicrobial activity of E. Coli ATCC 25922 as the representative strain. The minimum growth inhibition concentration (MIC) was measured and shown in Tables 1 and 2. At this time, as a comparative data, the new catalyst was ground and measured in the same manner as in Example 1 only.

제2도에 의하면 항균력이 거의 없는 신촉매에서 실시예 1의 제조방법으로 금속상 은을 염화은으로 바꾸어줌에 의하여 항균력 및 백색도를 증가시컬 수 있었으며, 염화은으로 바꾸어 주는 비율이 높아질수록 항균력 및 백색도가 증가함을 알 수 있다.According to FIG. 2, the antimicrobial activity and whiteness could be increased by changing the metallic silver to silver chloride in the preparation method of Example 1 in the new catalyst having almost no antimicrobial activity. It can be seen that increases.

실시예 3<균주별 항균작용시험>Example 3 <antibacterial activity test for each strain>

시료(1) 및 (4)에 대하여 일반세균 및 효모에 대하여 최소억제농도(MIC)를 측정하여 표 2에 나타내었다. 표 2에 표시된 바와 같이 실시예 1에 의하여 제조된 항균제는 특정한 균에만 작용하는 것이 아니고, 광범위한 균주에 대해서 효과가 있음을 발견하였다.For the samples (1) and (4), the minimum inhibitory concentration (MIC) of the general bacteria and yeast was measured and shown in Table 2. As shown in Table 2, it was found that the antimicrobial agent prepared by Example 1 did not act only on specific bacteria but was effective against a wide range of strains.

표 2TABLE 2

실시예 4 <독성시험>Example 4 <Toxicity Test>

독성시험은 시료(1)에 대해서 급성경구독성, AMES 시험, 중금속 용출시험결과를 실시하였다. 급성경구독성은 보건사회부 제87-80호(1987. 10. 29.)의 "의약품 안전성 시험관리기준"에 준하여 시험방법은 국립보건안전연구원 제94-3호(1994. 4.14.)의 "의약품등의 독성시혐기준"에 따라 SD 계통의 랫트에 암수 각각 0mg/kg 및 5000mg/kg의 용량으로 5마리씩 1회 경구투여하여 사망율, 일반증상, 체중변화 및 부검소견을 관찰한 결파 암수동물에 있어서 본 발명의 방법으로 제조된 시료의 투여에 기인한 사망동물, 일반증상, 체중변화 및 부검소견은 관찰되지 않았다. 따라서 본 발명의 방법으로 제조된 시료(1)의 LD60값은 5000mg/kg 이상으로 독성이 없는 화합물로 분류될 수 있었다. 미국의 켈리포니아 대학의 아메스 교수에 의하여 제안된 방법으로 미국환경보호청 및 일본의 노동성에서 돌연변이원성, 발암성 및 안정성의 판단기준으로 사용되는 AMES 시험은 살모넬라 티피머리움 AT100(Salmonella typhimurium TA100) 및 살모넬라 티피머리움 TA98(Salmonella typhimurium TA98) 세균에 일정농도의 시료를 투입하여 돌연변이의 발생을 관찰하는 것에 의하여 평가하였다. 본 발명의 방법으로 제조된 시료(1)을 500ug/ml, 1,000ug/ml, 10,000ug/ml, 50,000ug/ml의 농도가 되도록 DMSO(dimethyl sulfoxide)를 사용하여 희석한 것과 2-니트로플루오렌이 20mg/ml 되도록 DMSO에 녹인 용액을 대조균으로 하여 돌연변이를 관찰하였으나, 사용된 전 농도범위에서 돌연변이를 일으키지 않았다. 다시말해서 위의 시료(1)은 돌연변이에 음성인 것으로 나타났다. 따라서 위의 시료(1)가 급성경구독성에서 LD60값은 5000mg/kg으로 나타났다는 것은 식염의 LD60이 4000mg/kg 임을 반영하면 무독성임을 알 수 있으며, 돌연변이원성이 음성으로 나타나 특성이 거의 없는 항균성 화합물임을 알 수 있다.In the toxicity test, the results of acute oral toxicity, AMES test, and heavy metal dissolution test were performed on the sample (1). Acute oral toxicity is in accordance with the "Drug Safety Test Management Standards" of the Ministry of Health and Social Affairs 87-80 (October 29, 1987) .The test method is "Drugs" of No. 94-3 (April 14, 1994) of the National Institute of Health and Safety. To observe the mortality, general symptoms, weight change and autopsy findings by five oral doses of 0 mg / kg and 5000 mg / kg, respectively, in male and female rats of SD strains according to the Toxicity Criteria. No dead animals, general symptoms, body weight changes and necropsy findings due to administration of the samples prepared by the method of the present invention were observed. Therefore, the LD 60 value of the sample (1) prepared by the method of the present invention could be classified as a non-toxic compound of more than 5000mg / kg. The AMES test, proposed by Professor Ames of the University of California, USA, as a criterion for mutagenicity, carcinogenicity and stability in the US Environmental Protection Agency and the Labor Department in Japan, is the Salmonella typhimurium TA100 and Salmonella. Typhimurium TA98 (Salmonella typhimurium TA98) bacteria were evaluated by observing the occurrence of mutations by introducing a certain concentration of samples. Sample (1) prepared by the method of the present invention was diluted with DMSO (dimethyl sulfoxide) to a concentration of 500ug / ml, 1,000ug / ml, 10,000ug / ml, 50,000ug / ml and 2-nitrofluorene Mutation was observed using the solution dissolved in DMSO to 20 mg / ml as a control bacterium, but no mutation occurred in the entire concentration range used. In other words, the above sample (1) was found to be negative for the mutation. Therefore, the above sample (1) shows that LD 60 value is 5000mg / kg in acute oral toxicity, indicating that it is nontoxic when LD 60 of saline is 4000mg / kg. It can be seen that it is an antimicrobial compound.

실시예 5 <항균수지에 적용>Example 5 <Application to Antibacterial Resin>

실시예 1의 방법에 의하여 제조된 항균제 시료(1)을 LDPE(삼성종합화학(220S)에서 제조하여 판매)에 중량% 0.2부터 1.0의 비율로 반죽함으로써 수지에 첨가하여 항균력 및 항진균력을 평가하였다.The antimicrobial and antifungal activity of the antimicrobial agent 1 prepared by the method of Example 1 was added to the resin by kneading LDPE (manufactured by Samsung Synthetic Chemical, 220S) at a ratio of 0.2 to 1.0% by weight. .

항균력은 항균제 자체의 MIC와 비슷한 방법인 세이크 플라스크(Shaks Flask)법[방법: KS-K0693(직물의 항균도 시험방법 참조)]에 의하여 균감소율로 분석하였다. 이 방법은 시료 0.7g 내지 1g을 표면적이 60cm3되도록하여 플라스크에 넣고 시험균액을 접종 후 25℃에서 24시간 동안 진탕횟수가 150회/분되도록 진탕한 후 진탕전 후의 균수에다 초기균수를 나눈값인 균감소율을 평가기준으로 설정하였다. 표 3에 나타났듯이 미처리된 시료에서는 균수가 증가하였으나, 본 발명의 제조방법으로 제조된 항균제를 수지와 0.3중량% 혼합하는 것에 의하여 일반세균에 대하여 균감소율이 80% 이상으로 나타났다. 따라서 이와 같은 수지는 대장균(IFO 3972)과 황색포도상구균(IFO 12732)에 효과가 있기 때문에 위생도마, 물통등의 일반주방용품에 적합할 뿐만 아니라, 병원에서 가장 많이 발견되는 균인 황색포도상구균(MASA)에 대해서도 효과가 있기 때문에 병원용품에도 적합하다.The antimicrobial activity was analyzed by the shake flask (Shaks Flask method) method similar to the MIC of the antimicrobial agent itself (Method: KS-K0693 (see the antimicrobial test method of the fabric)) by the reduction rate. In this method, put 0.7g to 1g of sample in a flask with a surface area of 60cm 3 , shake the test bacteria with inoculation 150 times / min for 24 hours at 25 ° C, and divide the initial bacteria count after the shaking before the shaking. Phosphorus reduction rate was set as an evaluation standard. As shown in Table 3, the number of bacteria was increased in the untreated sample, but by reducing the antibacterial agent prepared by the method of the present invention with 0.3% by weight of the resin, the bacterial reduction rate was 80% or more with respect to general bacteria. Therefore, these resins are effective for E. coli (IFO 3972) and Staphylococcus aureus (IFO 12732), so they are not only suitable for general kitchen items such as sanitary cutting boards and water bottles, but also the most common bacteria found in hospitals. Also effective for), it is also suitable for hospital supplies.

항곰팡이성은 ASTM G21의 혼합균주 및 백선균을 사용하여 ASTM G21 방법에 의하여 실시하여 표 4에 나타내었다. 표 4에 나타났듯이 본 발명의 방법으로 제조된 항균제를 수지에 1.0중량% 혼합하는 것에 의하여 혼합균주 및 백선균이 자라나는 것이 미처리된 시료에 비하여 억제되는 것이 나타났다. 따라서 본 발명의 제조방법으로 제조된 항균제를 수지에 처방한 제품은 곰팡이에 대하여 효과가 있으므로곰팡이로부터 오염을 받는 신발밑창 등 위생용품 및 건축용품에 사용 가능하다.Antifungal properties are shown in Table 4 by the ASTM G21 method using a mixed strain and ringworm of ASTM G21. As shown in Table 4, it was shown that the growth of the mixed strain and ringworm bacteria was suppressed compared to the untreated sample by mixing 1.0 wt% of the antimicrobial agent prepared by the method of the present invention with the resin. Therefore, the product prescribed in the antimicrobial agent prepared in the resin of the present invention is effective against the mold, so it can be used in sanitary and construction supplies such as shoe soles that are contaminated from the mold.

표 3TABLE 3

표 4Table 4

제 1 도는 본 발명의 제조방법으로 제조된 무기계 항균제 및 원료인 촉매의 X-선 회절분석 그래프이고,1 is an X-ray diffraction graph of an inorganic antimicrobial agent and a catalyst which is a raw material prepared by the preparation method of the present invention.

제 2 도는 염소의 조성변화에 따른 최소성장억제농도(MIC) 및 백색도를 나타낸 그래프로서, 염소를 많이 함유할수록 최소성장 억제농도는 줄어들고(항균력은 증가하고) 백색도는 증가한다.2 is a graph showing the minimum growth inhibitory concentration (MIC) and the whiteness according to the change in the composition of chlorine, the more the chlorine contained, the minimum growth inhibitory concentration decreases (antibacterial activity increases) and the whiteness increases.

Claims (4)

은이 다공질 알루미나에 담지되어 있는 산화에틸렌 제조용 은담지 폐촉매를 음이온 도입반응, 소성, 분쇄 및 분급의 3단계로 처리하며, 상기 음이온 도입반응은 은담지 폐촉매 및 음이온을 반응기에 주입한 후 온도 0~50℃ 및 반응압력 1~10기압에서 반응시켜 수행되고, 상기 소성은 100∼300℃로 공기중에서 1~3시간 동안 수행되며, 상기 분쇄 및 분급은 촉매를 분쇄한 후 0.05∼20미크론의 평균입자크기를 갖는 입자를 분류하여 수행되는 것을 특징으로 하는 무기항균제 제조방법.The silver supported waste catalyst for producing ethylene oxide, in which silver is supported on porous alumina, is treated in three stages: anion introduction reaction, calcination, pulverization, and classification. The reaction is carried out at ~ 50 ℃ and reaction pressure 1 ~ 10 atm, the firing is carried out in the air at 100 ~ 300 ℃ for 1 to 3 hours, the grinding and classification is average of 0.05 to 20 microns after grinding the catalyst Method for producing an inorganic antimicrobial agent, characterized in that performed by classifying particles having a particle size. 제 1 항에 있어서, 음이온 도입반응에서 사용되는 음이온은 염소기, 질산기, 인산기, 수산기, 암모늄기, 아민기 또는 유기산기에서 선택되는 한가지 이상의 음이온인 것을 특징으로 하는 무기항균제 제조방법.The method of claim 1, wherein the anion used in the anion introduction reaction is at least one anion selected from chlorine, nitric acid, phosphoric acid, hydroxyl, ammonium, amine or organic acid groups. 제 2항에 있어서, 염소기를 도입함에 있어서 전체은에 대한 염소 이온의 함량을 0.5중량% 내지 24.7중량%를 가지도록 한 무기항균제 제조방법.The method for preparing an inorganic antibacterial agent according to claim 2, wherein the content of chlorine ions relative to the total silver is 0.5 wt% to 24.7 wt% in introducing chlorine groups. 제 1 항에 있어서, 염화은에 포함된 이온상의 은이 전체 은 대비 10중량% 내지 90중량%를 갖도록 한 무기항균제 제조방법.The method of claim 1, wherein the ionic phase silver contained in the silver chloride has 10% to 90% by weight of the total silver.
KR1019950069085A 1995-12-30 1995-12-30 Production of inorganic antimicrobial agent having high antibacterial potency suitable for manufacture of antimicrobial resin as well as improved color and low toxicity by treating waste supported silver catalyst KR100422568B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950069085A KR100422568B1 (en) 1995-12-30 1995-12-30 Production of inorganic antimicrobial agent having high antibacterial potency suitable for manufacture of antimicrobial resin as well as improved color and low toxicity by treating waste supported silver catalyst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950069085A KR100422568B1 (en) 1995-12-30 1995-12-30 Production of inorganic antimicrobial agent having high antibacterial potency suitable for manufacture of antimicrobial resin as well as improved color and low toxicity by treating waste supported silver catalyst

Publications (2)

Publication Number Publication Date
KR970032398A KR970032398A (en) 1997-07-22
KR100422568B1 true KR100422568B1 (en) 2004-08-25

Family

ID=37329087

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950069085A KR100422568B1 (en) 1995-12-30 1995-12-30 Production of inorganic antimicrobial agent having high antibacterial potency suitable for manufacture of antimicrobial resin as well as improved color and low toxicity by treating waste supported silver catalyst

Country Status (1)

Country Link
KR (1) KR100422568B1 (en)

Also Published As

Publication number Publication date
KR970032398A (en) 1997-07-22

Similar Documents

Publication Publication Date Title
CN100493696C (en) Doped zinc oxide and its preparation and application for photocatalysis degradation for organic matter and killing bacteria
CN105494429B (en) Antibacterial mildew preventive, preparation method thereof and antibacterial mildew preventive method
Imran et al. Polyvinylpyrrolidone and chitosan-coated magnetite (Fe3O4) nanoparticles for catalytic and antimicrobial activity with molecular docking analysis
EP1676582B1 (en) Anti-coronavirus agent
EP1832169B1 (en) Antimicrobial zeolite and antimicrobial composItion
KR101201590B1 (en) Method for controlling microbial contamination, mineral suspensions obtained and uses thereof
EP2035398B1 (en) Immobilized 1,2-benzisothiazolin-3-one
WO2001050864A1 (en) Antibacterial and mildew-proofing agents and antibactieral and mildew-proofing compositions
EP2671640A1 (en) Copper-and-titanium-containing composition and production method therefor
CN100525629C (en) Nano inorganic germicide and its preparation method
JPH09504022A (en) Improved antimicrobial composition
KR20190089665A (en) Method For preparing Inorganic Antimicrobial And Inorganic Antimicrobial Prepared By The Same Method
KR20110063402A (en) Antibacterial zeolite particles and antibacterial resin composition
CN104661961A (en) Method for preparing zirconium phosphate particles coated by antibiotic, and zirconium phosphate particles prepared thereby
WO2023140612A1 (en) Method for manufacturing adsorption material having excellent harmful gas removal and antibacterial deodorization functions by using ionization decomposition material
EP3915376A1 (en) Particulate antimicrobial hybrid system
Abbasifar et al. Antibacterial activity of silver nanoparticles synthesized by using extracts of Hedera helix
EP3175867A1 (en) Use of (hetero)polyoxometalates for simultaneously imparting antimicrobial properties to a surface of a substrate and reducing the growth of a biofilm on the surface of the substrate
CN107467084A (en) A kind of special disinfectant for aquaculture and its preparation
KR100422568B1 (en) Production of inorganic antimicrobial agent having high antibacterial potency suitable for manufacture of antimicrobial resin as well as improved color and low toxicity by treating waste supported silver catalyst
JPH10109906A (en) Antibacterial and fungicidal agent for industrial purposes
CN111363270A (en) Broad-spectrum antiviral bactericidal plastic and application thereof
KR100429164B1 (en) Production of inorganic antimicrobial agent by treating waste supported silver catalyst with dilute nitric acid to melt silver from catalyst while keeping silver chloride which is supported on carrier intact and production of antimicrobial resin composition having low toxicity and high antibacterial potency using inorganic antimicrobial agent
JP3300085B2 (en) Adsorbent composition and method for producing the same
CN106818866A (en) The bactericide of composite nanometer particle and its preparation and application

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130102

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20131211

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20141222

Year of fee payment: 12

EXPY Expiration of term